Ultrasound Guided Erector Spinae Plane Block

Not Applicable

Completed

• Conditions: Breast Diseases

• Registration Number: NCT06657092
• Lead Sponsor: Gözde Gamze Uzun

Brief Summary

Patients were randomized into two groups, ESP and control. Single-shot ultrasound (US)-guided ESP block with 20 ml 0.25% bupivacaine at the T4 vertebral level was performed preoperatively to all patients in the ESP group. The control group received no intervention. Patients in both groups were provided with intravenous patient-controlled analgesia device containing morphine for postoperative analgesia.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-03-04
• Primary Completion: 2022-12-20
• Study Completion: 2022-12-30
• Status Verified: 2023-02
• Study First Submitted: 2023-02-22
• Study First Submitted QC: 2024-10-22
• Study First Posted: 2024-10-24
• Last Update Submitted: 2024-10-24
• Last Update Posted: 2024-10-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 42

Inclusion Criteria

1. 18-65 age
2. Patients who scheduled for bilateral reduction mammoplasty
3. ASA Class I-II

Exclusion Criteria

1. Coagulopaty

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Total opioid consumption	Postoperative total opioid consumption in miligrams will be recorded at hour 24	Patients in both groups will receive opioid in postoperative period. Total opioid consumption in miligrams will be compared

Secondary Outcome Measures

Name	Time	Method
Intraoperative opioid consumption	At the end of the operation	The amount of remifentanyl administered to patients via intravenous infusion during the operation in micrograms, will be recorded.

Trial Locations

Locations (1)

Kocaeli Unıversity; 🇹🇷 Kocaeli, Izmit, Turkey